跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 210 条关于
“MEK1”
全部
210
临床试验
161
药物
16
机构
0
资讯
33
上个月
Newly Discovered BRAF Protein Conformation Offers Fresh Target for Cancer Drug Development
9个月前
Recursion's REC-4881 Shows Durable Polyp Reduction in Familial Adenomatous Polyposis Phase 2 Trial
9个月前
Recursion to Present Updated Clinical Data from Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis
去年
Pasithea's PAS-004 Outperforms FDA-Approved MEK Inhibitor in Preclinical IBD Study
去年
Koselugo Shows Promise in Adults with Neurofibromatosis Type 1 in Phase 3 Trial
去年
Meta-Analysis Confirms Tafinlar-Mekinist Combination's Efficacy Across Age Groups in Glioma Treatment
10个月前
Long-Term Mirdametinib Data Shows Improved Response Rates and Deeper Tumor Shrinkage in NF1-Associated Plexiform Neurofibromas
8个月前
BEAVER Trial Demonstrates Efficacy of Binimetinib-Encorafenib Combination in Advanced Non-V600E BRAF-Mutated Tumors
去年
Koselugo Meets Primary Endpoint in KOMET Phase III Trial for Adult NF1 Patients with Plexiform Neurofibromas
2个月前
Macrophage Metabolic Reprogramming Emerges as a Key Driver of Chronic Transplant Rejection and a New Therapeutic Target
第 1 页,共 4 页
上一页
下一页